Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

SGX301- A Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy of Topical SGX301 (Synthetic Hypericin) and Fluorescent Bulb-Light Irradiation for the Treatment of Cutaneous T-Cell Lymphoma


Collapse Overview 
Collapse sponsor award id
HPN-CTCL-01


Collapse Biography 

Collapse Time 
Collapse start date
2017-10-24

Collapse end date
2020-10-25